Harrow (HROW) Change in Acquisitions & Divestments (2013)
Harrow's (HROW) quarterly Change in Acquisitions & Divestments came in at -$50000.0 in Q1 2013.
Harrow (HROW) Change in Acquisitions & Divestments (2013) Analysis & Trends
Harrow's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at -$50000.0 for Q1 2013.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to -$50000.0 in Q1 2013; TTM through Dec 2013 was -$50000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $5.5 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments was little changed at -$50000.0 in Q1 2013 per HROW's latest filing.
- Across five years, Change in Acquisitions & Divestments topped out at -$50000.0 in Q1 2013 and bottomed at -$50000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Harrow | 1.44 Bn | 1.35 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -50,000.00 |
| Mar 31, 2013 | -50,000.00 |